Approvals/TGA/ZERBAXA ceftolozane sulfate/tazobactam sodium 1000 mg/500 mg powder for injection vial

Approved

STANDARD

ZERBAXA ceftolozane sulfate/tazobactam sodium 1000 mg/500 mg powder for injection vial

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cc5185c8d85892df
Product Name: ZERBAXA ceftolozane sulfate/tazobactam sodium 1000 mg/500 mg powder for injection vial
Artg Id: 229608
Artg Name: ZERBAXA ceftolozane sulfate/tazobactam sodium 1000 mg/500 mg powder for injection vial
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2015-11-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-02746-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-02745-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

cc5185c8d85892df

Type

Standard